Menu

Tag: heart disease

FDA Issues New Safety Communication on Clarithromycin Use in Patients with Heart Disease

Published March 1, 2018

On February 22nd, the Food & Drug Administration (FDA) issued a new drug safety communication to health care providers regarding the long-term risks of clarithromycin use in patients with heart disease.¬† Clarithromycin is a macrolide antibiotic used for treatment of a variety of respiratory tract and skin infections, and infections caused by¬†Helicobacter pylori and non-tuberculous… Read More

Page last reviewed: November 8, 2018